Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial JE Chaft, F Oezkan, MG Kris, PA Bunn, II Wistuba, DJ Kwiatkowski, ... Nature medicine 28 (10), 2155-2161, 2022 | 119 | 2022 |
AGO4 regulates entry into meiosis and influences silencing of sex chromosomes in the male mouse germline AJ Modzelewski, RJ Holmes, S Hilz, A Grimson, PE Cohen Developmental cell 23 (2), 251-264, 2012 | 117 | 2012 |
The roles of microRNAs and siRNAs in mammalian spermatogenesis S Hilz, AJ Modzelewski, PE Cohen, A Grimson Development 143 (17), 3061-3073, 2016 | 87 | 2016 |
Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma ST Magill, HN Vasudevan, K Seo, JE Villanueva-Meyer, A Choudhury, ... Nature communications 11 (1), 4803, 2020 | 78 | 2020 |
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas Y Yu, J Villanueva-Meyer, MR Grimmer, S Hilz, DA Solomon, S Choi, ... Neuro-oncology 23 (11), 1872-1884, 2021 | 55 | 2021 |
Dgcr8 and Dicer are essential for sex chromosome integrity during meiosis in males AJ Modzelewski, S Hilz, EA Crate, CTH Schweidenback, EA Fogarty, ... Journal of cell science 128 (12), 2314-2327, 2015 | 50 | 2015 |
Aberrant gene expression by Sertoli cells in infertile men with Sertoli cell-only syndrome DA Paduch, S Hilz, A Grimson, PN Schlegel, AE Jedlicka, WW Wright PLoS One 14 (5), e0216586, 2019 | 29 | 2019 |
Claudin 2 mRNA and Protein Are Present in Human Keratinocytes and May Be Regulated by All-< i> trans-</i> Retinoic Acid D Telgenhoff, S Ramsay, S Hilz, P Slusarewicz, B Shroot Skin pharmacology and physiology 21 (4), 211-217, 2008 | 27 | 2008 |
Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma LE Jones, S Hilz, MR Grimmer, T Mazor, C Najac, J Mukherjee, ... Neuro-oncology advances 2 (1), vdaa088, 2020 | 26 | 2020 |
Transcriptome profiling of the developing male germ line identifies the miR-29 family as a global regulator during meiosis S Hilz, EA Fogarty, AJ Modzelewski, PE Cohen, A Grimson RNA biology 14 (2), 219-235, 2017 | 26 | 2017 |
Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features EA Sloan, S Hilz, R Gupta, C Cadwell, B Ramani, J Hofmann, CN Kline, ... Acta neuropathologica 139, 953-957, 2020 | 23 | 2020 |
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications E Mohamed, A Kumar, Y Zhang, AS Wang, K Chen, Y Lim, A Shai, ... Neuro-oncology 24 (9), 1471-1481, 2022 | 22 | 2022 |
A20 and ABIN1 suppression of a keratinocyte inflammatory program with a shared single-cell expression signature in diverse human rashes P Harirchian, J Lee, S Hilz, AJ Sedgewick, BEP White, MJ Kesling, T Mully, ... Journal of Investigative Dermatology 139 (6), 1264-1273, 2019 | 17 | 2019 |
Artificial intelligence (AI)–powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer … S Dacic, WD Travis, JM Giltnane, J Abel, F Kos, S Hilz, S Hennek, ... Journal of Clinical Oncology 39 (15_suppl), 106-106, 2021 | 16 | 2021 |
Intratumor and informatic heterogeneity influence meningioma molecular classification HN Vasudevan, A Choudhury, S Hilz, JE Villanueva-Meyer, WC Chen, ... Acta neuropathologica 144 (3), 579-583, 2022 | 13 | 2022 |
Multiplatform molecular profiling reveals epigenomic intratumor heterogeneity in ependymoma SJ Liu, ST Magill, HN Vasudevan, S Hilz, JE Villanueva-Meyer, S Lastella, ... Cell reports 30 (5), 1300-1309. e5, 2020 | 11 | 2020 |
MA09. 01 LCMC3: Immune cell subtypes predict nodal status and pathologic response after neoadjuvant atezolizumab in resectable NSCLC F Oezkan, M Seweryn, M Pietrzak, WY Byun, D Owen, K Schulze, ... Journal of Thoracic Oncology 16 (10), S910-S911, 2021 | 10 | 2021 |
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective R Mathur, Q Wang, PG Schupp, A Nikolic, S Hilz, C Hong, NR Grishanina, ... Cell 187 (2), 446-463. e16, 2024 | 8 | 2024 |
Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study S Dacic, WD Travis, JM Giltnane, F Kos, J Abel, S Hilz, J Fujimoto, L Sholl, ... Journal of Thoracic Oncology 19 (5), 719-731, 2024 | 4 | 2024 |
Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant … NA Oberheim Bush, Y Yu, J Villanueva-Meyer, M Grimmer, S Hilz, ... Journal of Clinical Oncology 38 (15_suppl), 2506-2506, 2020 | 4 | 2020 |